|Articles|April 30, 2021
SEC Separation of ADC Brentuximab Vedotin
Author(s)YMC Europe GmbH
The antibody-drug conjugate was separated from its aggregates and fragments in only one run using a YMC-SEC MAB column and varying mobile phases.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
GC-MS & GC-IMS Reveal Black Tea Aroma Secrets
3
GC-MS Detection of Microbes in Spacecraft Water
4
Best of the Week: Chromatography Methods, HPLC 2026 Previews, and More
5